Processes for the preparation of normorphinan salts
View Patent ↗The invention provides a process for the conversion of opioid derivatives into normorphinan compounds useful for making “nal” compound analgesics and antagonists. In particular, the process may be used for the production of pure normorphinan salts from crude opioid substrates.
1. A process for the preparation of compound 2 from compound 1 according to the following reaction:
wherein:
R 1 is selected from the group consisting of hydrogen, hydrocarbyl and substituted hydrocarbyl;
R 1a is an oxygen protecting group;
R 2 is selected from the group consisting of alkyl and aryl;
R 3 , R 4 and R 5 , are independently selected from the group consisting of hydrogen, halogen, hydroxyl, methoxy, {—}OR 8 , hydrocarbyl, and substituted hydrocarbyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl and hydrocarbyl;
R 8 is selected from the group consisting of hydrocarbyl, and substituted hydrocarbyl; and
X is halogen selected from the group consisting of Cl, and Br.
2. The process of claim 1 , wherein:
R 1 is selected from the group consisting of hydrogen, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, and alkoxycarbonyl;
R 2 is alkyl;
R 3 , R 4 and R 5 , are independently selected from the group consisting of hydrogen, halogen, hydroxyl, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, alkoxycarbonyl, and carbonyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl, alkyl and aryl; and
X is chloride.
3. The process of claim 1 , wherein the proton acceptor has a pKa of greater than about 7; the reaction is conduced in the presence of an aprotic solvent; the molar ratio of compound 1 to XCO 2 R 2 to proton acceptor is from about 1:3:1 to about 1:20:20, and the reaction is conducted at a temperature ranging from about 50° C. to about 80° C.
4. The process of claim 1 , wherein compound 2 comprises a mixture of compounds selected from the group consisting of noroxymorphone derivatives and noroxycodone derivatives.
5. The process of claim 1 , wherein the process results in the formation of side product compounds not having formula 2, and the reaction mixture separates into an organic layer, and an aqueous layer after the reaction mixture is quenched with a protic solvent.
6. The process of claim 5 , wherein the side product compounds and compounds having formula 1 are removed from the reaction mixture by a wash step, the wash step comprising contacting the organic layer with a pro tic solvent having a pH from about 0.8 to about 2.0, followed by separation of the aqueous layer from the reaction mixture.
7. The process of claim 6 , wherein the amount of compound 1 and side product compounds remaining in the organic layer after the wash step comprises from about 0.01% to about 2% area/area of the organic layer; and the amount of compound 2 remaining in the organic layer after the wash step comprises from about 80% to about 99% area/area of the organic layer.
8. The process of claim 6 , wherein the aprotic solvent is displaced with a second solvent selected from the group consisting of an alcohol having from 3 to 8 carbon atoms, and a proton donor having from 2 to 8 carbon atoms.
9. A process for the preparation of compound 3 from compound 2 according to the following reaction:
wherein:
R 1 is selected from the group consisting of hydrogen, hydrocarbyl and substituted hydrocarbyl;
R 1a is an oxygen protecting group;
R 2 is selected from the group consisting of alkyl and aryl;
R 3 , R 4 and R 5 , are independently selected from the group consisting of hydrogen, halogen, hydroxyl, {—}OR 8 , hydrocarbyl, and substituted hydrocarbyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl and hydrocarbyl;
R 7 is selected from the group consisting of proton donors having a pKa less than about 0;
R 8 is selected from the group consisting of hydrocarbyl, and substituted hydrocarbyl.
10. The process of claim 9 , wherein:
R 1 is selected from the group consisting of hydrogen, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, and alkoxycarbonyl;
R 2 is alkyl;
R 3 , R 4 and R 5 , are independently selected from the group consisting of hydrogen, halogen, hydroxyl, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, alkoxycarbonyl, carbonyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl, alkyl and aryl;
R 7 is selected from the group consisting of sulfuric acid, methanesulfonic acid, toluenesulfonic acid, phosphoric acid, hydrochloric acid, and hydrobromic acid.
11. The process of claim 9 , wherein the proton donor has a pKa less than 0.
12. The process of claim 9 , wherein the proton donor is selected from the group consisting of sulfuric acid, methanesulfonic acid, toluenesulfonic acid, phosphoric acid, hydrochloric acid, and hydrobromic acid;
the reaction is conducted in the presence of at least one pro tic solvent, the amount of protic solvent to compound 2 is about 2:1 (g/g), the molar ratio of compound 2 to proton donor is from about 1:1.5 to about 1:10 (g/g), and the reaction is conducted at a temperature ranging from about 90° C. to about 115° C.
13. The process of claim 9 , wherein the reactants comprise compound 2, a proton donor, a protic solvent, and a second proton donor having from 2 to 8 carbon atoms.
14. The process of claim 13 , wherein compound 2 comprises a mixture of noroxymorphone derivatives, the proton donor is methanesulfonic acid, the protic solvent is water, the second proton donor is propionic acid; and compound 3 is noroxymorphone.MeSO 3 H.
15. The process of claim 13 , wherein compound 2 comprises a mixture of noroxycodone derivatives, the proton donor is methanesulfonic acid, the protic solvent is water, the second proton donor is propionic acid; and compound 3 is noroxycodone methanesulfonate.
16. The process of claim 9 , wherein compound 3 is formed as a crystal; the yield of compound 3 is from about 65% to about 85% (mol/mol); and the purity of compound 3 is at least 95% as determined by chromatography.
17. A process for the preparation of compound 3, the process comprising a first reaction that comprises contacting compound 1 with a proton acceptor and XCO 2 R 2 to form compound 2, and a second reaction that comprises contacting compound 2 with a proton donor to form compound 3 according to the following reaction scheme:
wherein:
R 1 is selected from the group consisting of hydrogen, hydrocarbyl and substituted hydrocarbyl;
R 1a is an oxygen protecting group;
R 2 is selected from the group consisting of alkyl and aryl;
R 3 , R 4 and R 5 , are independently selected from the group consisting of hydrogen, halogen, hydroxyl, {—}OR 8 , hydrocarbyl, and substituted hydrocarbyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl and hydrocarbyl;
R 7 is selected from the group consisting of proton donors having a pKa less than about 0;
R 8 is selected from the group consisting of hydrocarbyl and substituted hydrocarbyl; and
X is halogen selected from the group consisting of Cl, and Br.
18. The process of claim 17 , wherein:
R 1 is selected from the group consisting of hydrogen, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, and alkoxycarbonyl;
R 2 is alkyl;
R 3 , R 4 and R 5 are independently selected from the group consisting of hydrogen, halogen, hydroxyl, acyl, alkyl, alkenyl, aryl, substituted alkyl, substituted alkenyl, substituted aryl, alkoxycarbonyl, carbonyl;
R 6 is selected from the group consisting of hydrogen, halogen, hydroxyl, alkyl and aryl;
R 7 is selected from the group consisting of sulfuric acid, methanesulfonic acid, toluenesulfonic acid, phosphoric acid, hydrochloric acid, and hydrobromic acid; and
X is chloride.
19. The process of claim 17 , wherein the proton acceptor has a pKa of greater than about 7; the first reaction is conduced in the presence of an aprotic solvent; the molar ratio of compound 1 to XCO 2 R 2 to proton acceptor is from about 1:3:1 to about 1:20:20, the first reaction is conducted at a temperature ranging from about 50° C. to about 80° C.; compound 2 comprises a mixture of compounds selected from the group consisting of noroxymorphone derivatives and noroxycodone derivatives; the proton donor has a pKa less than 0; the second reaction is conducted in the presence of at least one protic solvent, the amount of pro tic solvent to compound 2 is about 2:1 (g/g), the molar ratio of compound 2 to proton donor is from about 1:1.5 to about 1:10 (gig), and the second reaction is conducted at a temperature ranging from about 90° C. to about 115° C.
20. The process of claim 17 , wherein the process results in the formation of side product compounds not having formula 2, and the reaction mixture separates into an organic layer, and an aqueous layer after the reaction mixture is quenched with a protic solvent.
21. The process of claim 20 , wherein the side product compounds and compounds having formula 1 are removed from the reaction mixture by a wash step, the wash step comprising contacting the organic layer with a protic solvent having a pH from about 0.8 to about 2.0, followed by separation of the aqueous layer from the reaction mixture.
22. The process of claim 21 , wherein the aprotic solvent is displaced with a second solvent selected from the group consisting of an alcohol having from 3 to 8 carbon atoms, and a proton donor having from 2 to 8 carbon atoms.
23. The process of claim 17 , wherein compound 3 is formed as a crystal; the yield of compound 3 is from about 65% to about 85% (mol/mol); the purity of compound 3 is at least 95% as determined by chromatography.
24. The process of claim 17 , wherein the optical activity of compound 1, 2, or 3 is selected from the group consisting of (−) enantiomer, (+) enantiomer, and a combination thereof.
25. The process of claim 17 , wherein the configuration of carbons 5, 13, 14, and 9, respectively, of compounds 1, 2, or 3 is selected from the group consisting RRRS, RRSS, SRRS, SRSS, RSRR, RSSR, SSRR, and SSSR.